Prevalence and determinants of elevated D-dimer in patients with hypertrophic cardiomyopathy

Chengzhi Yang1, Changlin Zhang2, Jiansong Yuan2

  • 1Department of Cardiology and Macrovascular Disease, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

Biomarkers in Medicine
|February 15, 2020
PubMed

Insights

Patients with hypertrophic cardiomyopathy (HCM) may have elevated D-dimer levels. Age, sex, and statin therapy are key factors influencing these D-dimer levels in HCM patients.

Area of Science:

  • Cardiology
  • Biomarkers

Background:

  • Hypertrophic cardiomyopathy (HCM) is a complex cardiac condition.
  • Understanding associated biomarkers like D-dimer is crucial for patient management.

Purpose of the Study:

  • To investigate D-dimer levels in patients diagnosed with hypertrophic cardiomyopathy.
  • To identify factors associated with elevated D-dimer in this population.

Main Methods:

  • Recruited 346 patients with hypertrophic cardiomyopathy (HCM).
  • Measured plasma D-dimer levels using standard laboratory methods.
  • Assessed cardiac function parameters including left ventricular mass, stroke volume, cardiac output, and cardiac index via cardiovascular magnetic resonance imaging.

Main Results:

  • 10.4% of HCM patients exhibited elevated D-dimer levels.
  • Independent predictors for elevated D-dimer included older age, female sex, and statin therapy.
  • Atrial fibrillation and diastolic blood pressure also influenced D-dimer levels.

Conclusions:

  • Plasma D-dimer levels may be elevated in patients with hypertrophic cardiomyopathy compared to healthy individuals.
  • D-dimer levels in HCM are multifactorial, influenced by demographic and clinical factors.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
304
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
373
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
371
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
424
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
797
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
252